Fisher Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-6,601
Closed -$291K 946
2021
Q2
$291K Buy
6,601
+258
+4% +$12.6K ﹤0.01% 810
2021
Q1
$313K Hold
6,343
﹤0.01% 778
2020
Q4
$267K Sell
6,343
-100
-2% -$4.4K ﹤0.01% 817
2020
Q3
$295K Sell
6,443
-2,686
-29% -$130K ﹤0.01% 743
2020
Q2
$458K Sell
9,129
-2,992
-25% -$155K ﹤0.01% 670
2020
Q1
$623K Buy
12,121
+29
+0.2% +$1.55K ﹤0.01% 596
2019
Q4
$747K Hold
12,092
﹤0.01% 620
2019
Q3
$726K Hold
12,092
﹤0.01% 639
2019
Q2
$1.02M Sell
12,092
-197
-2% -$17.7K ﹤0.01% 602
2019
Q1
$1.17M Buy
12,289
+75
+0.6% +$6.73K ﹤0.01% 576
2018
Q4
$865K Hold
12,214
﹤0.01% 605
2018
Q3
$1.04M Sell
12,214
-2,469
-17% -$247K ﹤0.01% 579
2018
Q2
$1.7M Sell
14,683
-5,014
-25% -$500K ﹤0.01% 543
2018
Q1
$1.59M Buy
+19,697
New +$1.52M ﹤0.01% 536

Other funds holding ENTA